ACR releases guideline for managing ILD in patients with rheumatic diseaseAugust 30, 2023Autoimmune Diseases
A 75-year-old White woman presented with diffuse erythema, scale, and pruritus on her scalpAugust 16, 2023Medical DermatologyAutoimmune DiseasesRare Diseases
Autoantibody against enteric nervous system protein linked to GI dysfunction in systemic sclerosisAugust 8, 2023Autoimmune DiseasesRare Diseases
A 45-year-old White woman with no significant medical history presented with a 1-month history of lesions on the nose and right cheekAugust 7, 2023Autoimmune DiseasesMedical Dermatology
Autoantibodies could help predict cancer risk in sclerodermaAugust 4, 2023Mixed TopicsAutoimmune Diseases
FDA approves ritlecitinib for ages 12 and up for alopecia areataJune 26, 2023Hair & NailsPediatricsAutoimmune DiseasesRare Diseases
New EULAR lupus recommendations advise using biologics, tapering steroidsJune 14, 2023Autoimmune Diseases
Patient selection key to lowering placebo response rates in lupus clinical trialsJune 13, 2023Autoimmune Diseases
EULAR systemic sclerosis recommendations now include immunosuppressantsJune 5, 2023Autoimmune DiseasesRare Diseases
Encouraging telitacicept results reported in phase 3 for lupus, phase 2 for Sjögren’sJune 2, 2023Autoimmune Diseases
Scientists discover variants, therapy for disabling pansclerotic morpheaJune 2, 2023Autoimmune DiseasesRare DiseasesMedical DermatologyMixed Topics
Investigational lupus drug cenerimod moves to phase 3 studies after equivocal phase 2 resultsMay 26, 2023Autoimmune Diseases
